For some trees, wasted bark is a potential treasure-trove of biopharmaceuticals—from anti-inflammatories to cancer-fighting ...

FDA Commissioner Martin Makary, MD, shared his vision for a “New FDA” with biopharma leaders attending BIO in Boston.

The ability to make patient-specific products quickly fits with the needs of smaller, resource-limited developers.

Noetik will use its multimodal AI models to identify which patients will most likely benefit from Agenus’s lead ...

Barcelona’s blood and tissue bank says it has developed a new system for the large-scale production of mesenchymal stromal ...

Bionova will also use Cytiva’s Fast Trak process development services to help advance their entry into genomic medicines.

The AI unicorn's Perturb-seq atlas is publicly available and detects dose-dependent genetic effects to enhance predictive ...

QurAlis’ new headquarters offers enhanced lab and discovery resources and a 5,000-sq-ft conferencing space for meeting and ...

In addition to being faster and less invasive than a traditional tissue biopsy, the blood test is also potentially more ...

By designing proteins de novo scientists can more efficiently create novel therapeutics tailored for specific biological ...

A Roots Analysis study showed the market for ADC manufacturing is $1.79 billion today, but is expected to grow to $7 billion ...

Chrysalis partners with life science clients, from early-stage biofirms to pharmaceutical firms, CROs, and other life science ...